Cadence Pharmaceuticals™

Investor Relations

Cadence Pharmaceuticals, Inc. is a biopharmaceutical company focused on in-licensing, developing and commercializing proprietary product candidates principally for use in the hospital setting.

Recent Releases

Nov 6, 2008
Cadence Pharmaceuticals Reports Third Quarter 2008 Financial Results and Provides Clinical Development Programs Update

Oct 29, 2008
Cadence Pharmaceuticals to Host Conference Call and Webcast to Discuss Third Quarter 2008 Financial Results and Provide a Clinical Program Update on November 6, 2008

Events

Nov 6, 2008
Cadence Pharmaceuticals 3rd Quarter Earnings Release

Oct 28, 2008
BIOCOM San Diego Investor Conference

more »
Print page Print
Email page Email


Stock Quote
CADX - (NASD)
$5.55   - 0.45
Nov 20, 2008
4:00 PM ET

Quotes delayed at
least 20 minutes.
Information provided
by eSignal.

©2005 Cadence™ Pharmaceuticals. All rights reserved. No portion of cadencepharm.com may be duplicated, redistributed or manipulated in any form. CADENCE and OMIGARD are trademarks of Cadence Pharmaceuticals, Inc.